<DOC>
	<DOCNO>NCT00309543</DOCNO>
	<brief_summary>This clinical investigation examine influence cytostatic chemotherapy 5-fluorouracil , modulate biologically active leucovorin , patient â€™ survival time follow surgery colon carcinoma Stage II .</brief_summary>
	<brief_title>Randomized Trial Adjuvant Chemotherapy Colon Carcinoma Dukes B</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Patients histologically verify , operable colon carcinoma Stage II ( RO , T34 , N0 , M0 ) Age : less 80 year WHO Performance &gt; 2 Adequate bone marrow reserve , renal hepatic function Informed consent Rectal cancer R1or R2 resection ; carcinosis peritonei Start treatment &gt; 42 day postop ; adjuvant radiotherapy , chemotherapy immunotherapy Serious concomitant disease , particular chronically inflammatory large intestine , cardiopathic metabolic disease , malignant second carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Fluorouracil</keyword>
	<keyword>Leucovorin</keyword>
	<keyword>Colon cancer</keyword>
</DOC>